Week of February 21, 2023 | Vol. 12, Issue 7

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities

Catalent - Feb 14, 2023

Astrea Bioseparations to Combine with Biotage AB, Creating Global Chromatography Leader

PR Newswire - Feb 15, 2023

Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration

Business Wire - Feb 15, 2023

Dalton Announces Major Expansion in Commercial Sterile Manufacturing Capacity

PR Newswire - Feb 16, 2023

Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company

Business Wire - Feb 16, 2023

Lonza Completes Expansion of Conjugation Facility in Visp (CH)

Lonza - Feb 16, 2023

LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership for N-LIfT Allogeneic Neutrophil Based Cell Therapy

B3C Newswire - Feb 16, 2023

TANNER NEWS

Enabling Access to Medicine

There are instances where patients may experience interruptions in treatment access, entirely lose access they once had, or completely lack access to a medicine that just isn’t available where they live. Tanner EVPs Maryori Alvarenga and John Lagus share more about these challenges and the opportunities to overcome them. Access the full article.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.